BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28458531)

  • 1. Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
    Thulborn SJ; Dilpazir M; Haldar K; Mistry V; Brightling CE; Barer MR; Bafadhel M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1199-1205. PubMed ID: 28458531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.
    Bafadhel M; Haldar K; Barker B; Patel H; Mistry V; Barer MR; Pavord ID; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1075-83. PubMed ID: 26089657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD is associated with reduced pulmonary interstitial expression of pentraxin-3.
    Van Pottelberge GR; Bracke KR; Pauwels NS; Vermassen FE; Joos GF; Brusselle GG
    Eur Respir J; 2012 Apr; 39(4):830-8. PubMed ID: 21920889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
    Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
    Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 sputum levels differ in patients with chronic obstructive pulmonary disease vs asthma.
    Schwingel FL; Pizzichini E; Kleveston T; Morato EF; Pinheiro JT; Steidle LJ; Dal-Pizzol F; Rocha CC; Pizzichini MM
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):485-9. PubMed ID: 26508705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum pentraxin 3 as a candidate to assess airway inflammation and remodeling in childhood asthma.
    Kim MJ; Lee HS; Sol IS; Kim MN; Hong JY; Lee KE; Kim YH; Kim KW; Sohn MH; Kim KE
    Medicine (Baltimore); 2016 Dec; 95(51):e5677. PubMed ID: 28002338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    PLoS One; 2013; 8(1):e53661. PubMed ID: 23341967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin levels in non-eosinophilic versus eosinophilic asthma.
    Gao P; Tang K; Wang M; Yang Q; Xu Y; Wang J; Zhao J; Xie J
    Clin Exp Allergy; 2018 Aug; 48(8):981-989. PubMed ID: 29754456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
    Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
    Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil elastase as a biomarker for bacterial infection in COPD.
    Thulborn SJ; Mistry V; Brightling CE; Moffitt KL; Ribeiro D; Bafadhel M
    Respir Res; 2019 Jul; 20(1):170. PubMed ID: 31362723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
    Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers.
    Zhang Y; Tedrow J; Nouraie M; Li X; Chandra D; Bon J; Kass DJ; Fuhrman CR; Leader JK; Duncan SR; Kaminski N; Sciurba FC
    Thorax; 2021 Apr; 76(4):335-342. PubMed ID: 33479043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
    Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
    Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD.
    Scherr A; Graf R; Bain M; Christ-Crain M; Müller B; Tamm M; Stolz D
    Chest; 2013 Feb; 143(2):379-387. PubMed ID: 22922487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease.
    Kurt OK; Tosun M; Kurt EB; Talay F
    Inflammation; 2015 Feb; 38(1):89-93. PubMed ID: 25303877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.
    Hamon Y; Jaillon S; Person C; Giniès JL; Garo E; Bottazzi B; Ghamrawi S; Urban T; Subra JF; Bouchara JP; Mantovani A; Jeannin P; Delneste Y
    Innate Immun; 2013 Dec; 19(6):611-22. PubMed ID: 23475792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.
    Aydemir Y; Aydemir Ö; Kalem F
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1045-51. PubMed ID: 25298733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.